INTRODUCTION
Burn wound infections are significant causes of morbidity and mortality, and they are ultimately responsible for 50 -75 % of deaths. Acinetobacter baumannii is widely dispersed as an important opportunistic pathogen, especially in burn patients, all over the world [1] . Increasing resistance in this bacterium complicates the selection of suitable empirical therapy in severe infections, such as burn wound injuries. The carbapenems are broadly regarded as a suitable option for the treatment of severe infections caused by multidrug-resistant A. baumannii (MR-AB) [2] . In the low-income countries, the incidence of carbapenem-resistant A. baumannii (CR-AB) infections is increasing at an alarming rate, especially among hospitalized burn patients [3] . Carbapenem resistance in A. baumannii is related to several combined mechanisms, such as the acquisition of β-lactamases, AmpC stable derepression, low outer membrane permeability, altered penicillin-binding proteins (PBPs), and less frequently, efflux pump overexpression [4] . Especially, oxacillinase (OXA)-type β-lactamases (Ambler class D enzymes) and metallo-β-lactamases (MBL; Ambler class B enzymes) have been identified worldwide from CR-AB strains. MBL enzymes, including IMP, VIM, SPM, GIM, SIM, AIM, FIM, and NDM, are zincdependent carbapenemases; they are inhibited by EDTA and play a crucial role in drug resistance against carbapenems. OXAs, which are not inhibited by EDTA and/or clavulanic acid, are subdivided into six families, as follows: the OXA-23-like, OXA-24/40-like, OXA-51-like, OXA-58-like, OXA-143-like, and OXA-182-like families [4, 5] .
Carbapenemases have a high ability to spread, since their encoding genes have usually been found in transferable plasmids comprising integrons and insertion sequence (IS) determinants. Integrons are assembly genetic platforms/DNA segments that can gain gene cassettes carrying antibiotic-resistance elements via a site-specific recombination. These genetic elements are recognized by the presence of three essential apparatuses for producing exogenous genes, as follows: an integrase (intI gene), attI (a recombination site), and P C (a promoter). The most common types of integrons are transportable class I, followed by class II and III integrons [3, 6] . In recent years, A. baumannii strains producing MBL-, OXA-, and KPC-type carbapenemases have been increasingly found in Iran [2] . This study was performed to determine the antibiotic resistance profiles and frequencies of MBL-, OXA-, and KPC-encoding determinants and int genes in A. baumannii isolated from pediatric burn patients in Tehran, Iran.
EXPERIMENTAL Ethical approval
The study was approved by the ethical committee of Iran University of Medical Sciences (IUMS), Tehran, Iran (consent ref no. IR.IUMS.REC 1395.9221133207). Written informed consent form was collected from the patients or a close relative. Identifying information of each sample was kept secret. Each stage of sampling was done in such a way as to minimize pain and harm to the patients and international guidelines for human studies were followed [7] .
Sampling and bacterial isolates
This cross-sectional study was performed on patients hospitalized at the pediatric ward of the Motahari Burn and Reconstruction Center in Tehran, Iran, from October 2016 to June 2017. The Motahari burn hospital is one of the specialized burn centers in our country, providing care to burn cases from Tehran (the capital of Iran) and patients with complications who have been referred from other therapeutic centers across the country. The hospital currently operates under the Iran University of Medical Sciences (IUMS). Burns patients were recruited according as per Bowler et al [1] . A. baumannii was initially identified using biochemical and microbiological procedures and then, confirmed using an API 20 NE Kit (version 6.0, bioMérieux, Marcy l'Étoile, France). Each isolate was preserved in Luria-Bertani broth (Merck Co., Germany) containing 20 % glycerol (v/v) at -80 °C for further use. A. baumannii ATCC 19606 was used as a quality control.
Antimicrobial susceptibility testing
An antimicrobial susceptibility test was conducted using the disk agar diffusion (DAD) assay, as suggested by the Clinical and Laboratory Standards Institute (CLSI document M100-S14) [8] , on Mueller-Hinton agar (MHA) plates for the 11 following antimicrobials: levofloxacin (LEV; 5 µg); ceftazidime (CAZ; 30 µg), cefotaxime (CTX; 30 µg), piperacillin/tazobactam (TZP; 100/10 µg), imipenem (IPM; 10 µg), ciprofloxacin (CIP; 5 µg), tobramycin (TOB; 10 μg), gentamicin (GM; 10 µg), piperacillin (PIP; 100 µg), tetracycline (TET; 30 µg), and trimethoprim-sulfamethoxazole (SXT; 5 µg; MAST Diagnostics, Merseyside, UK).
Multidrug-resistant (MDR), extensively drugresistant (XDR), and pan-drug-resistant (PDR) isolates were identified based on the guidelines suggested by the Centers for Disease Control and Prevention (CDC). Each strain was tested for colistin (CL) and IPM susceptibility using an E-test in line with the manufacturer's guidelines (Liofilchem SRL, Roseto degli Abruzzi, Italy). The Liofilchem MIC Test Strips (MTS) for colistin (CS; drug concentration gradient of 0.016 -256 mg/ml, with interpretative criteria of susceptible [S], ≤ 2 μg/ml, resistant [R], ≥ 4 μg/ml) and IPM (range: 0.002 -32 µg/ml, MIC interpretative criteria of S, ≤ 4 µg/ml, R, ≥ 16 µg/ml) were used. The strips were placed onto MHA medium with an added bacterial suspension equal to 0.5 McFarland. After incubation at 37 °C for 18 -24 h, E-test MICs were determined as the point of interception of the zone of inhibited growth with the strips.
Identification of the MBL phenotype
For the identification of MBL-producing isolates, a combined disk diffusion test (CDDT) was performed. Concisely, a 0.5 McFarland turbidity of the bacterial suspension was streaked on an MHA plate. Then, two 10-μg IPM disks were placed on the MHA plates; following this, 10 μL of MBL inhibitor solution (0.5 M EDTA) was added to one of the IPM disks to reach a desired concentration of 750 mg. After 24 h of incubation at 35 °C, the inhibition zone diameters of all disks were recorded and compared. The isolates were considered MBL-producing isolates when the difference in the inhibition zones was observed to be ≥ 7 mm. In addition, MBL E-test MIC values (IPM [range: 4 -256 μg/mL] and IPM/EDTA [IMD; range: 1 -64 μg/mL]; Liofilchem SRL) was done according to the company's instructions. An IPM/IMD ratio ≥ 8 μg/L was considered positive.
Modified hodge test (MHT)
The Modified Hodge test (MHT) was performed in all IPM-resistant isolates according to the CLSI guideline to identify carbapenemase-producing organisms. An overnight suspension of Escherichia coli ATCC 25922 equivalent to the turbidity of the 0.5 McFarland standard was streaked on MHA using a sterile cotton swab. Then, a 10-μg meropenem disk (HI-MEDIA, Mumbai, India) was placed at the center of the petri dish, and the test isolate was cultured from the edge of the disk to the margin of the plate in four orders. The presence of a 'cloverleafshaped' inhibition zone after 24 h incubation at 37 °C was considered as a positive test result.
Polymerase chain reaction (PCR)
A DNA Extraction Kit (Bioneer Company, Korea, Cat. number K-3032-2) was used to extract genomic DNA from the colonies grown overnight in brain heart infusion agar plates. The concentration and quality of the total genomic DNA extracted were evaluated using a NanoDrop™ 1000 Spectrophotometer (Thermo Scientific, Wilmington, DE, USA). DNA isolates with a concentration of 0.1 ng/µl were used as the templates for polymerase chain reaction (PCR) assay. 
RESULTS
In general, 73 non-duplicative burned wound samples were collected from the patients (n = 41, 56.2 % female; n = 32, 43.8 % male). The mean age of the patients studied was 8.5 years, with a range of 4 -17 years. The antimicrobial susceptibility results are shown in Table 2 . The frequencies of MDR and XDR isolates were 92.4 and 38.3 %, respectively. Moreover, 94.5 % (n = 69/73) of the strains were resistant to IPM, as determined by both the DAD and MIC E-test methods. The results of the E-test showed that CL was the most effective antimicrobial, with a susceptibility rate of 98.6 %. Only 1.4 % (n = 1) of the isolates were resistant to CL in the MTS with the interpretative criterion of ≥ 4 μg/ml. Among the 69 IPM-resistant A. baumannii, 82.6 % (n = 57) and 88.4 % (n = 61) were MBL producers, as determined by the CDDT and Etest methods, respectively. In the MHT, 13 % (n = 9/69) of the strains were positively identified as KPC-producing isolates, as they developed a cloverleaf shape; however, only 5.8 % (n = 4/69) of isolates carried the bla KPC gene. The Int gene was found in 91.7 % (n = 67/73) of the isolates.
The molecular analyses of class I, II, and III integrons showed that 16.4 % (n = 11/67), 76.1 % (n = 51/67), and 7.5 % (n = 5/67) of the strains harbored the intI, intII, and intIII genes, respectively. The coexistence of intI/intII and intI/intII/intIII in isolates were 11.9 % (n = 8) and 2.9 % (n = 2), respectively. 
DISCUSSION
The rapid emergence of MDR-AB and XDR-AB strains in recent years has become an important concern for treatment of hospital acquired infections, especially in burn patients [7] . The results of this study, which supported the findings of other studies [14, 15] , revealed the presence of A. baumannii strains with multiple resistances to antimicrobials in our hospital. Furthermore, we found a high resistance rate to carbapenems (94.5 %), a class of antibiotics that used to be the drug of choice. Similarly, Shoja et al [11] showed that 92.5 % of A. baumannii isolated from burn patients were resistant to carbapenems, and therefore, these agents are not suitable for the treatment of infections.
Polymyxins, such as CL, are effective agents against the overwhelming majority of A. baumannii throughout the world. In a systematic review study conducted by Razavi et al [16] , polymyxins showed adequate activity against A. baumannii isolated from 2006 to 2013; in their results, 77 -100 % of isolates were susceptible to CL. Furthermore, they found no significant change in the resistance of isolates to this antibiotic during the study period. Similarly, we found that 98.6 % of isolates were susceptible to CL. These findings indicate that CL has increasingly become the last viable therapeutic choice for MDR-AB infections.
It has been suggested that OXA-type carbapenemases play an important role in carbapenem resistance in A. baumannii. Outbreaks of CR-AB harboring the bla OXA-23-like gene occurs in 31 % to 100 % worldwide [12] . The prevalence of the bla OXA-23-like and bla like genes in the current study were 75.4 and 39.1 %, respectively. Quiñones et al [17] showed that 75 % of CR-AB isolates harbored different bla OXA genes (bla OXA-23 : 73 %, bla OXA-24 : 18 %, bla OXA-58 : 3 %), which suggests that these OXAs may be locally spread. Moreover, Farshadzadeh et al [18] showed that the broad distribution of the bla OXA-23-like gene was the main reason for the rapid increase in the carbapenem resistance rate among burn patients in Iran.
It has been reported that when screening for carbapenemases, two confounders must be ruled out, as follows: (i) not all carbapenemresistant strains produce a carbapenemase, and (ii) not all carbapenemase producers are resistant to carbapenems [19] . The carbapenemresistant strains in this study were screened using the MHT and IMD methods, which have been effectively used to validate carbapenemase producers. These tests can also discriminate carbapenem-resistance mediated by carbapenemases from that mediated by other mechanisms. The present study showed that carbapenem-resistance was chiefly caused by MBLs. However, the observed low rates of carbapenemase activity in MHT among CR-AB could have emerged because the identification of carbapenemase activity in clinical strains is challenging [20] ; the MHT method suffers from low sensitivity, and interpretation of its results can be subjective (the cloverleaf indentation). Thirteen percent of KPC-producing isolates were found phenotypically, but only 5.8 % of isolates were positive for the bla KPC gene. This contrast may have been due to reduced susceptibility to at least one extended-spectrum cephalosporin and another mechanism, such as carbapenem resistance due to a combination of an extendedspectrum beta-lactamases (ESBLs) or AmpCtype enzyme with porin loss [21] .
In the present study, bla VIM was the most prevalent MBL-encoding gene tested (62.3 %), followed by bla IMP (30.4 %) and bla NDM (4.3 %). In a study performed by Fallah et al [22] , 17.4 and 3.5 % of A. baumannii isolates were positive for the bla VIM and bla IMP genes, respectively. Yousefi et al [9] showed that bla IMP was more important, especially among the clinical isolates of Pseudomonas aeruginosa in Iran. Regarding the relatively high frequency of bla NDM in our study, it is important to note that bla NDM was primarily recognized in India, and only later was it reported from other countries, such as Pakistan. The proximity of these countries to Iran and the large number of visits and immigration between the states on the one hand and the ease of resistance transfer among the organisms on the other led us to think that it may be feasible for our strains to have a similar gene. In concordance with Fallah et al [22] , these studies are valuable for preventing the spread of resistant organisms to other parts of the world.
In this work, 91.7 % of A. baumannii isolates carried genes encoding integrase, a necessary element for integron functions. Our results showed that class II integron was the most prevalent in our isolates, which agreed with the results of Deylam Salehi et al [14] and Mirnejad et al [23] , but contrasted with the reports of Lin et al [24] and Taherikalani et al [15] . Chen et al [25] showed that detection of integrons is an indicator for evaluating MDR-AB epidemics. The differences in the prevalence of integron types in previous studies and the present one are most likely owing to the geographical distance, surveillance strategies, and restraint in antibiotic prescriptions in other regions.
CONCLUSION
The findings of this study demonstrate a high prevalence of CR-AB isolates that carry various encoding genes and could produce carbapenemases at the study site. Rapid and precise identification of these strains is necessary for selection of suitable antimicrobial therapy, controlling their inter-or intra-hospital spread, and ultimately, diminishing related infections, especially in burn patients.
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